IRIS
ANGELICO, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 90.682
AS - Asia 8.894
EU - Europa 6.996
SA - Sud America 1.178
AF - Africa 116
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 16
Totale 107.899
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 90.506
SG - Singapore 4.286
CN - Cina 1.986
UA - Ucraina 1.223
DE - Germania 1.112
RU - Federazione Russa 1.008
BR - Brasile 984
HK - Hong Kong 893
IE - Irlanda 765
VN - Vietnam 633
IT - Italia 619
SE - Svezia 486
FI - Finlandia 473
FR - Francia 459
KR - Corea 340
GB - Regno Unito 328
PL - Polonia 228
JP - Giappone 173
IN - India 159
CA - Canada 94
BD - Bangladesh 66
AR - Argentina 61
NL - Olanda 58
MX - Messico 56
ID - Indonesia 46
AT - Austria 43
IQ - Iraq 43
BE - Belgio 42
TR - Turchia 40
ZA - Sudafrica 38
EC - Ecuador 36
ES - Italia 36
PK - Pakistan 28
CZ - Repubblica Ceca 27
CO - Colombia 24
CL - Cile 21
UZ - Uzbekistan 19
VE - Venezuela 19
EG - Egitto 17
IL - Israele 17
RO - Romania 17
AU - Australia 14
AE - Emirati Arabi Uniti 13
PY - Paraguay 13
SA - Arabia Saudita 12
CH - Svizzera 11
JO - Giordania 11
MY - Malesia 11
TN - Tunisia 11
IR - Iran 10
MA - Marocco 10
EU - Europa 9
KG - Kirghizistan 9
LT - Lituania 9
NP - Nepal 9
PE - Perù 9
TH - Thailandia 9
DZ - Algeria 8
ET - Etiopia 8
KZ - Kazakistan 8
TW - Taiwan 8
UY - Uruguay 8
AZ - Azerbaigian 7
PH - Filippine 7
A2 - ???statistics.table.value.countryCode.A2??? 6
LK - Sri Lanka 6
MD - Moldavia 6
OM - Oman 6
AL - Albania 5
SY - Repubblica araba siriana 5
AO - Angola 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
GR - Grecia 4
HN - Honduras 4
HR - Croazia 4
KE - Kenya 4
KW - Kuwait 4
LB - Libano 4
MN - Mongolia 4
PT - Portogallo 4
TM - Turkmenistan 4
BG - Bulgaria 3
BH - Bahrain 3
BO - Bolivia 3
DM - Dominica 3
HU - Ungheria 3
NG - Nigeria 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BB - Barbados 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
DK - Danimarca 2
GA - Gabon 2
GE - Georgia 2
Totale 107.862
Salva come PNG Salva come JPEG
Città #
Woodbridge 27.063
Wilmington 23.497
Houston 21.574
Fairfield 2.713
Singapore 2.038
Ann Arbor 1.967
Ashburn 1.460
Jacksonville 1.134
Seattle 1.107
Chandler 1.075
Cambridge 909
San Jose 894
Hong Kong 880
Beijing 750
Dublin 745
Medford 574
Dearborn 515
New York 479
Santa Clara 332
The Dalles 281
Lawrence 266
Rome 241
Helsinki 220
Los Angeles 206
Zhengzhou 203
Mülheim 190
Ho Chi Minh City 185
Kraków 174
Hanoi 166
Lauterbourg 153
Moscow 146
Buffalo 140
Hangzhou 137
San Diego 136
Tokyo 132
Menlo Park 121
Council Bluffs 113
São Paulo 106
Milan 86
Dallas 75
Orem 74
Shanghai 64
Munich 56
Palo Alto 53
University Park 52
Chicago 51
London 51
Chennai 47
Frankfurt am Main 47
Warsaw 47
Mountain View 46
Jersey City 45
Hefei 42
San Francisco 42
Norwalk 41
Falls Church 40
Nuremberg 39
Phoenix 39
Redwood City 38
Boardman 36
San Mateo 36
Brussels 35
Guangzhou 35
Nanjing 35
Atlanta 34
Verona 33
Denver 32
Detroit 31
Stockholm 31
Columbus 30
Johannesburg 29
Manchester 29
Redondo Beach 29
Brooklyn 27
Montreal 27
Rio de Janeiro 24
Kunming 23
Haiphong 22
Seoul 22
Toronto 21
Indiana 20
Mexico City 20
Amsterdam 19
Jakarta 18
Vienna 17
Baghdad 16
Belo Horizonte 16
Jinan 16
Mumbai 16
North Bergen 16
Paris 16
Poplar 16
Tashkent 16
Biên Hòa 15
Curitiba 15
Dhaka 15
Nanchang 15
Saint Petersburg 15
Da Nang 14
Ankara 13
Totale 95.042
Salva come PNG Salva come JPEG
Nome #
Crusted scabies in a liver transplant patient mimicking rupioid psoriasis 1.396
Hepatitis C reinfection after liver transplantation in relation to virus genotype 607
Boceprevir for untreated chronic HCV genotype 1 infection. 593
Maintenance ribavirin monotherapy delays fibrosis progression in liver transplant recipients with recurrent hepatitis C at high risk of progression 577
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 577
Tauroursodeoxycholate reduces ischemic damage in human allografts: a biochemical and ultrastructural study 553
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 543
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. 522
HCV-RNA quantification in liver bioptic samples and extrahepatic compartments, using the abbott RealTime HCV assay 519
Transport, utilization and biliary secretion of lysophosphatidylcholine in the rat liver 513
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice 507
Recurrence of insulin resistant metabolic syndrome following liver transplantation 506
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C. 505
Cyclosporine A versus tacrolimus monotherapy. Comparison on bile lipids in the first 3 months after liver transplant in humans 497
Downstaging disease in patients with hepatocellular carcinoma outside up-to-seven criteria: Strategies using degradable starch microspheres transcatheter arterial chemo-embolization 497
Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence 493
Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation. 491
Unfavourable effects of colchicine in combination with interferon-alpha in the treatment of chronic hepatitis C 490
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro 487
Operational tolerance in clinical liver transplantation: emerging developments. 486
A simple rule to personalize standard dual therapy across all genotypes in naive chronic hepatitis C patients: The TT4 randomized trial 485
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 485
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression 484
Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practice 484
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome 484
Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs. 478
Lamivudine-resistance mutations can be selected even at very low levels of hepatitis B viraemia 477
Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: Two case reports 477
Primary yolk sac tumor of the liver: incidental finding in a patient transplanted for hepatocellular carcinoma 475
Role of MRI with hepatospecific contrast agent in the identification and characterization of focal liver lesions: pathological correlation in explanted livers 474
A randomized controlled trial of amantadine plus interferon-alpha 2a vs. interferon-alpha 2a alone in naive patients with chronic hepatitis C randomized according to the early virological response to interferon-alpha 2a monotherapy 473
Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infection 473
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 473
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting. 468
Correlation between liver fibrosis and inflammation in patients transplanted for HCV liver disease 467
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients 465
Taurohyodeoxycholate- and tauroursodeoxycholate-induced hypercholeresis is augmented in bile duct ligated rats 464
Ribavirin increases mitogen- and antigen-induced expression of CD40L on CD4+ T cells in vivo. 463
Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. 461
Liver transplantation for Wilson's disease: The burden of neurological and psychiatric disorders 460
Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: Potent antiviral activity but no clinical benefit if treatment is given late 460
Role of hepatitis B virus genetic barrier in drug-resistance and immune-escape development 457
Leptin attenuates ischemia-reperfusion injury in the rat liver. 457
Optimal efficacy of interferon-free HCV retreatment after protease inhibitors failure in real life. 457
Comment on the PROVE1 and PROVE2 clinical trials: "I was taking a picture of Rapid Virological Response with telaprevir, but the background is unfocused!". 456
Activation of the IGF1 system characterizes cholangiocyte survival during progression of primary biliary cirrhosis 455
In vivo, high field, 3-Tesla H MR spectroscopic asessment of liver in fibrosis in HCV-correlated chronic liver disease Valutazione in vivo della fibrosi epatica in corso di epatopatia cronica HCV con spettroscopia H-RM 3T 454
Lamellar bodies coexist with vesicles and micelles in human gallbladder bile. Ursodeoxycholic acid prevents cholesterol crystal nucleation by increasing biliary lamellae 454
Interposition of the right colic angle between the liver and thoracic wall: an unusual cause of massive rectal bleeding following percutaneous biopsy in a liver transplant recipient. 453
596 453
Clinical trial: low plasma cholesterol and oxidative stress predict rapid virological response to standard therapy with peginterferon and ribavirin in HCV patients 453
Recipient female gender is a risk factor for graft loss after liver transplantation for chronic hepatitis C: Evidence from the prospective Liver Match cohort 453
Assembly of biliary lipids in native hepatic bile after orthotopic liver transplantation: a biochemical and ultra-structural study in humans 452
HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors 452
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study 451
Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha 450
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection. 450
Plasma/erythrocyte ribavirin x100 ratio as an indicator of sustained virological response in HCV genotype 1 patients with early virological response 447
N-ethyl-tauroursodeoxycholic acid, a novel deconjugation-resistant bile salt analogue: effects of acute feeding in the rat 447
Specific HbsAg genetic determinants are associated with occult HBV infection in vivo and HbsAg detection 447
Pitfalls in the reporting of upper endoscopy features in cirrhotic patients 446
Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension 445
Liver elasticity in NASH patients evaluated with real-time elastography (RTE). 445
Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation. 444
Liver contrast enhanced ultrasound perfusion imaging in the evaluation of chronic hepatitis C fibrosis: preliminary results 444
Specific HBSAG Genetic- Determinants are associated with occult HBV-infection in vivo and HBSAG detection 444
Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study 444
A randomized controlled trial of pegylated interferon-alpha2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B 443
A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation 442
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting 441
Extended HBV vaccination in liver transplant recipients for HBV-related cirrhosis: report of two successful cases. 441
Effect of glucose and/or branched chain amino acid infusion on plasma amino acid imbalance in chronic liver failure 439
Quasielastic light scattering evidence for vesicular secretion of biliary lipids 439
Complete hbv prophylaxis withdrawal in HBsAg-positive liver transplant recipients after long-term minimal immunosuppression 439
Interposition of the right colic angle between the liver and thoracic wall: An unusual cause of massive rectal bleeding following percutaneous biopsy in a liver transplant recipient 438
Low-dose hepatitis B immunoglobulin given "on demand" in combination with lamivudine: a highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term follow-up after liver transplantation. 437
High performance liquid chromatographic analysis of molecular species of phosphatidylcholine--development of quantitative assay and its application to human bile 437
Retrospective analysis of 30 patients who underwent liver transplantation without use of steroids 436
Dissolution of human cholesterol gallstones in bile salt/lecithin mixtures: effect of bile salt hydrophobicity and various pHs 436
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 436
Sequential changes in serum and biliary bile acids after liver transplantation 433
A survey on mortality from non-variceal upper gastrointestinal bleeding: Is the emergency referral system adequate? 433
Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C 432
Liver transplantation for end-stage liver disease related to viral hepatitis 431
Extended double-dosage HBV vaccination after liver transplantation is ineffective, in the absence of lamivudine and prior wash-out of human Hepatitis B immunoglobulins 431
Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen 431
Skills and requirements of a transplant hepatologist: board certification of the Italian Association for the Study of the Liver (AISF) 430
Evidence of Spontaneous Post-transplant HCV Eradication in Two Failed DAA Treatments Awaiting Liver Transplantation 429
Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease 428
One-year pilot study on tauroursodeoxycholic acid as an adjuvant treatment after liver transplantation 428
13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. 428
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C 427
White Paper of Italian Gastroenterology: Delivery of services for digestive diseases in Italy: Weaknesses and strengths 427
Molecular epidemiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitis 426
Qualitative patterns of biliary bile acids affect cyclosporine intestinal absorption in liver transplant recipients 426
Key patterns of HBX and pre-S1/S2 mutations are involved in mechanisms underlying HBV-induced hepatocellular carcinoma in vivo 426
Bile acids with differing hydrophilic-hydrophobic properties do not influence cytokine production by human monocytes and murine Kupffer cells 425
Spontaneous resolution of severe acute rejection in liver transplantation. 425
International comparison of liver transplant programmes: differences in indications, donor and recipient selection and outcome between Italy and UK 425
Portal vein thrombosis after radiofrequency ablation of HCC 424
Totale 47.268
Salva come PNG Salva come JPEG
Categoria #
all - tutte 222.901
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 222.901
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.048 0 0 0 0 0 0 0 0 0 311 576 161
2021/20222.774 122 278 162 157 64 361 120 113 269 247 109 772
2022/20233.203 376 233 124 345 252 743 271 185 300 28 284 62
2023/2024862 134 21 85 20 91 215 14 22 11 23 7 219
2024/20256.089 187 1.289 617 335 114 475 299 228 543 386 867 749
2025/20268.995 747 432 1.024 907 844 549 1.244 1.446 994 808 0 0
Totale 108.420